Cellect Biotechnology Gets European Patent (APOP) – Investopedia

Posted: April 4, 2017 at 1:50 am

Cellect Biotechnology Gets European Patent (APOP)
Investopedia
secured a European patent covering a method of treatment from the European Patent Office. The patent covers cell-based therapeutics of Cellect's technology and method that have the potential to treat diseases like diabetes, graft-versus-host disease, ...
BRIEF-Cellect Biotechnology receives formal notice of intention to grant for a patent from European patent officeReuters
Cellect Biotechnology (APOP) Granted European Patents Protecting ...StreetInsider.com
Cellect Biotechnology Ltd. (NASDAQ:APOP) reported an European patent grantBenchmark Monitor
GlobeNewswire (press release)
all 9 news articles »

Read more here:
Cellect Biotechnology Gets European Patent (APOP) - Investopedia

Related Post